1 / 2

Non-Invasive Prenatal Testing Market Size & Share

Non-Invasive Prenatal Testing Market

Manisha109
Télécharger la présentation

Non-Invasive Prenatal Testing Market Size & Share

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Non-invasive Prenatal Testing Market Analysis The global Non-Invasive Prenatal Testing (NIPT) market is projected to grow from $6.07 billion in 2023 to $19.09 billion by 2030, with a compound annual growth rate of 17.8%. Market Leadership North America dominates the global market with a 51.15% share as of 2022, driven by:  High incidence of Down syndrome (1 in 700 U.S. births)  Strong presence of key testing providers  Advanced healthcare infrastructure Key Growth Drivers 1.Rising maternal age 2.Increasing chromosomal abnormalities 3.Technological innovations in screening methods 4.Integration into public healthcare systems Recent Strategic Developments  September 2022: YOURGENE HEALTH received approval for IONA Nx NIPT Workflow in Singapore  September 2022: Eurofins Genoma launched non-invasive preimplantation genetic aneuploidy screening  August 2022: Natera filed FDA pre-submission for Panorama NIPT Market Segments By Technology  Next-Generation Sequencing (NGS) - largest segment  Microarray  Polymerase Chain Reaction (PCR)  Rolling Circular Amplification By End User  Clinical Laboratories - dominant segment  Hospitals Key Market Players Leading companies include:  Illumina, Inc.  YOURGENE HEALTH

  2. Natera  F. Hoffmann-La Roche Ltd  PerkinElmer Inc.  Laboratory Corporation of America Market Challenges  High testing costs ($350-400 in India)  Limited awareness in developing markets  Inadequate reimbursement policies  Access barriers in low-income regions Report- Fortune Business Insights - Non-invasive Prenatal Testing Market Size | Share, 2030 https://www.fortunebusinessinsights.com/industry-reports/non-invasive-prenatal-testing-market- 100998

More Related